Literature DB >> 30168729

Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury.

Stefano Toldo1,2,3, Adolfo G Mauro1,2, Zachary Cutter1,2, Antonio Abbate1,2.   

Abstract

Myocardial ischemia-reperfusion injury induces a sterile inflammatory response, leading to further injury that contributes to the final infarct size. Locally released danger-associated molecular patterns lead to priming and triggering of the NOD-like receptor protein 3 inflammasome and amplification of the inflammatory response and cell death by activation of caspase-1. We review strategies inhibiting priming, triggering, or caspase-1 activity or blockade of the inflammasome-related cytokines interleukin-1β and interleukin-18, focusing on the beneficial effects in experimental models of acute myocardial infarction in animals and the initial results of clinical translational research trials.

Entities:  

Keywords:  inflammasome; interleukin-18; interleukin-1β; ischemia-reperfusion injury; nucleotide-binding oligomerization domain-like receptor protein 3

Mesh:

Substances:

Year:  2018        PMID: 30168729      PMCID: PMC6336966          DOI: 10.1152/ajpheart.00158.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  150 in total

1.  Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse.

Authors:  Antonio Abbate; Benjamin W Van Tassell; Ignacio M Seropian; Stefano Toldo; Roshanak Robati; Amit Varma; Fadi N Salloum; Lisa Smithson; Charles A Dinarello
Journal:  Eur J Heart Fail       Date:  2010-04       Impact factor: 15.534

Review 2.  Interleukin 1α and the inflammatory process.

Authors:  Nelson C Di Paolo; Dmitry M Shayakhmetov
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

3.  The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.

Authors:  Øystein Sandanger; Trine Ranheim; Leif Erik Vinge; Marte Bliksøen; Katrine Alfsnes; Alexandra V Finsen; Christen P Dahl; Erik T Askevold; Geir Florholmen; Geir Christensen; Katherine A Fitzgerald; Egil Lien; Guro Valen; Terje Espevik; Pål Aukrust; Arne Yndestad
Journal:  Cardiovasc Res       Date:  2013-04-10       Impact factor: 10.787

4.  MyD88, an adapter protein involved in interleukin-1 signaling.

Authors:  K Burns; F Martinon; C Esslinger; H Pahl; P Schneider; J L Bodmer; F Di Marco; L French; J Tschopp
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

5.  Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain.

Authors:  Nicole B Bryan; Andrea Dorfleutner; Yon Rojanasakul; Christian Stehlik
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 6.  Targeting interleukin-1 in heart failure and inflammatory heart disease.

Authors:  Benjamin W Van Tassell; Juan M Valle Raleigh; Antonio Abbate
Journal:  Curr Heart Fail Rep       Date:  2015-02

7.  Role of NLRP3 (cryopyrin) in acute myocardial infarction.

Authors:  Eleonora Mezzaroma; Stefano Toldo; Antonio Abbate
Journal:  Cardiovasc Res       Date:  2013-05-21       Impact factor: 10.787

8.  Differences in signaling pathways by IL-1beta and IL-18.

Authors:  Jae-Kwon Lee; Soo-Hyun Kim; Eli C Lewis; Tania Azam; Leonid L Reznikov; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

9.  Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse.

Authors:  Antonio Abbate; Fadi N Salloum; Benjamin W Van Tassell; Elena Vecile; Stefano Toldo; Ignacio Seropian; Eleonora Mezzaroma; Aldo Dobrina
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

10.  An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1.

Authors:  Niall S Kenneth; J Michael Younger; Elizabeth D Hughes; Danielle Marcotte; Philip A Barker; Thomas L Saunders; Colin S Duckett
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

View more
  81 in total

Review 1.  Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling.

Authors:  Takeshi Suetomi; Shigeki Miyamoto; Joan Heller Brown
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-23       Impact factor: 4.733

Review 2.  Reactive species-induced microvascular dysfunction in ischemia/reperfusion.

Authors:  Hong Yu; Ted Kalogeris; Ronald J Korthuis
Journal:  Free Radic Biol Med       Date:  2019-03-05       Impact factor: 7.376

3.  Intermittent high glucose induces pyroptosis of rat H9C2 cardiomyocytes via sodium-glucose cotransporter 1.

Authors:  Qian Chai; Ziang Meng; Dexue Lu; Ziying Zhang; Meili Liu; Weihua Wu
Journal:  Mol Cell Biochem       Date:  2021-02-19       Impact factor: 3.396

4.  Alda-1, an Activator of ALDH2, Improves Postresuscitation Cardiac and Neurological Outcomes by Inhibiting Pyroptosis in Swine.

Authors:  Mengyuan Diao; Jiefeng Xu; Jiangang Wang; Minhai Zhang; Chenghao Wu; Xin Hu; Ying Zhu; Mao Zhang; Wei Hu
Journal:  Neurochem Res       Date:  2022-01-30       Impact factor: 3.996

Review 5.  Research on natural products from traditional Chinese medicine in the treatment of myocardial ischemia-reperfusion injury.

Authors:  Wenyu Bu; Zhaoyang Zhang; Dickson Kofi Wiredu Ocansey; Zhihua Yu; Xiao Yang; Zhitong Liu; Xinyu Wang; Yuhe Ke
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 6.  Guidelines for evaluating myocardial cell death.

Authors:  Paras K Mishra; Adriana Adameova; Joseph A Hill; Christopher P Baines; Peter M Kang; James M Downey; Jagat Narula; Masafumi Takahashi; Antonio Abbate; Hande C Piristine; Sumit Kar; Shi Su; Jason K Higa; Nicholas K Kawasaki; Takashi Matsui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-16       Impact factor: 4.733

Review 7.  Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.

Authors:  Antonio Abbate; Stefano Toldo; Carlo Marchetti; Jordana Kron; Benjamin W Van Tassell; Charles A Dinarello
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 8.  Different types of cell death in vascular diseases.

Authors:  Shirin Saberianpour; Abbas Karimi; Mohammad Hadi Saeed Modaghegh; Mahdi Ahmadi
Journal:  Mol Biol Rep       Date:  2021-05-19       Impact factor: 2.316

Review 9.  Fibroblast contributions to ischemic cardiac remodeling.

Authors:  Ryan M Burke; Kimberly N Burgos Villar; Eric M Small
Journal:  Cell Signal       Date:  2020-11-02       Impact factor: 4.315

10.  Overexpression of miR-1298 attenuates myocardial ischemia-reperfusion injury by targeting PP2A.

Authors:  Chun Ouyang; Lei Huang; Xiaoqiang Ye; Mingming Ren; Zhen Han
Journal:  J Thromb Thrombolysis       Date:  2021-08-05       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.